Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide vs Fluticasone Propionate in Persistent Asthma
NCT00163319Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2004
- Modality
- Orthosteric Ligands
- Countries
- 7
01
Overview
Phase 3, randomised, open-label trial of ciclesonide in asthma (2 arms), sponsored by AstraZeneca. Primary endpoint: Number of patients with candidiasis of the oropharynx or hoarseness. Started Nov 2004; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00163319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00163319.